当前位置:首页 - 行情中心 - 金石亚药(300434) - 财务分析 - 利润表

金石亚药

(300434)

  

流通市值:28.76亿  总市值:34.51亿
流通股本:3.35亿   总股本:4.02亿

利润表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、营业总收入362,785,115.791,209,199,438.06827,063,956.04633,725,687.05
营业收入362,785,115.791,209,199,438.06827,063,956.04633,725,687.05
二、营业总成本247,274,368.45958,207,145.35651,362,855.09440,502,846.95
营业成本140,822,731.84466,915,362.63329,349,823.66229,053,357.49
税金及附加5,298,537.6422,989,65011,029,950.038,505,267.04
销售费用54,552,466.55262,895,365.82156,857,766.5799,737,852.05
管理费用39,529,763.1166,938,485.28119,906,812.6478,230,171.23
研发费用8,503,028.0850,011,112.6640,018,123.0527,863,062.95
财务费用-1,432,158.76-11,542,831.04-5,799,620.86-2,886,863.81
其中:利息费用232,908.93671,747.562,393,815.391,969,797.99
其中:利息收入1,575,982.1112,091,408.877,556,710.13,938,373.46
加:投资收益-2,639,662.66-18,427,831.35-11,963,049.57-7,695,194.39
资产处置收益12,227.4250,297.58255,814.79255,814.79
资产减值损失(新)22,129.06-67,771,974.1711,038.137,850.42
信用减值损失(新)-119,669.344,461,667.371,004,905.13-1,042,820.22
其他收益2,263,152.318,434,727.66,615,972.665,523,784.68
营业利润平衡项目0000
四、营业利润115,048,924.11177,939,179.74171,625,782.06190,302,275.38
加:营业外收入1,051,323.6660,858.91650,552.2638,906.41
减:营业外支出531,654.881,582,695.33445,858.77269,719.96
利润总额平衡项目0000
五、利润总额115,568,592.83177,017,343.32171,830,475.49190,671,461.83
减:所得税费用26,024,942.5256,305,726.1636,334,569.1236,931,725.76
六、净利润89,543,650.31120,711,617.16135,495,906.37153,739,736.07
持续经营净利润89,543,650.31120,711,617.16-153,739,736.07
终止经营净利润0---
归属于母公司股东的净利润89,816,224.68126,199,723.64138,782,369.86155,730,458.83
少数股东损益-272,574.37-5,488,106.48-3,286,463.49-1,990,722.76
(一)基本每股收益0.220.310.350.39
(二)稀释每股收益0.220.310.350.39
九、综合收益总额89,543,650.31120,711,617.16135,495,906.37153,739,736.07
归属于母公司股东的综合收益总额89,816,224.68126,199,723.64138,782,369.86155,730,458.83
归属于少数股东的综合收益总额-272,574.37-5,488,106.48-3,286,463.49-1,990,722.76
公告日期2024-04-262024-04-262023-10-302023-08-29
审计意见(境内)标准无保留意见
TOP↑